Funding · Healthcare & Life Sciences

Plazza seeks $6M for expansion despite denial

By Startup Enthusiast · 27 March 2026

What they do

Plazza delivers medicines within 60 minutes using partnered pharmacies and dark stores

Reports say Z47 Partners leads a $6M round while existing investors participate

Cofounder Aman Priyadarshi denies capital raising talks contradicting the reported funding status

Plazza is reportedly in talks to raise approximately $6 million in fresh funding.
Z47 Partners is likely to lead this new investment round.
Existing investors All In Capital and Better Capital are expected to participate.
The company previously raised $1.2 million roughly six months before this current report.
Cofounder Aman Priyadarshi has denied that the company is currently raising capital.
This denial conflicts with the original reports of an ongoing fundraising process.
The story highlights a discrepancy between public statements and market reports.
Plazza aims to use funds to expand operations and set up more dark stores.

The Indian quick commerce market is projected to grow from $6.1 billion to $40 billion by 2030.
Plazza operates only in select pincodes in Bengaluru rather than expanding nationally yet.
The conflict between denial and reporting suggests sensitive or unconfirmed deal stages.
Competitors include established players like Tata 1mg and Apollo Pharmacy.

Plazza functions as a quick medicine delivery platform targeting 60-minute delivery times.
It serves customers in Bengaluru through partnerships with seven licensed pharmacies.
The inventory includes over 20,000 SKUs of medicines and monitoring devices.
Delivery services operate 24 hours a day for customer convenience.
The company launched a physical store named Lifestore in Yemalur.
Plazza focuses on specific localities rather than covering the entire city.
Infrastructure relies on dark stores to facilitate rapid order fulfillment.
The business model emphasizes speed and availability of essential health products.

Z47 Partners (lead) — Likely lead investor for the $6M round.
All In Capital (existing) — Existing investor likely to participate in the new round.
Better Capital (existing) — Existing investor likely to participate in the new round.

Product: medicine delivery startup
Customers: Consumers seeking rapid medicine delivery with comprehensive pharmaceutical selection
How it makes money: Quick commerce pharmacy platform with AI-powered inventory management for 15-30 minute delivery
What sets it apart: AI inventory management and higher fill rates (40,000+ SKUs vs typical 5,000)